Single agent maintenance therapy is widely accepted for advanced non-squamous non small cell lung cancer (NSCLC).
Research suggests that methadone maintenance therapy is especially effective at helping people remain in treatment, perhaps because of ongoing clinical monitoring.
Many researchers believe that methadone maintenance therapy is an essential component of treatment but say that, for a variety of reasons, it is often not readily available to addicts.
Maintenance therapy is thus added and is expected to be gentle with the safest profile post ASCT, but unlike consolidation, it is administered long-term to deepen the response, prevent progression, and prolong OS5.
Although bacillus Calmette-Guérin (BCG) is currently regarded as the most effective treatment available for the management of non muscle-invasive bladder canon muscle-invasiveenance bladderunderutilised and debate still remains as to whether the routine use of maintenancancerrapy is required for optimal outcomes.
This idea, known as maintenance therapy, is a new one, although Eli Lilly's Alimta has shown success as a maintenance therapy in lung cancer.
Lithium maintenance therapy is strongly recommended for the long-term management of selected patients with unipolar depression since there is strong evidence for its episode-preventing efficacy and unique anti-suicidal effects.
We refer to World Federation of Societies of Biological Psychiatry WFSBPP) Guidelines on Maintenance Treatment of Major Depressive that recommended "maintenance therapy is most commonly appropriate for recurrent patients, particularly when an episode prior to the present one has occurred in the last 5 years or when remission has been difficult to achieve.
Maintenance therapy is appropriate in patients with EE.
Whether all patients will ultimately require maintenance therapy is unclear.
Maintenance therapy is essential for most mCRC patients.
